Back to User profile » Dr Shinji Fujikoshi
Papers published by Dr Shinji Fujikoshi:
Longitudinal Assessment of Pain Management Among the Employed Japanese Population with Knee Osteoarthritis
Ueda K, Takura T, Fujikoshi S, Meyers J, Nagar SP, Enomoto H
Clinical Interventions in Aging 2020, 15:1003-1012
Published Date: 26 June 2020
Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
Enomoto H, Fujikoshi S, Ogawa K, Tsuji T, Tanaka S
Journal of Pain Research 2020, 13:181-191
Published Date: 20 January 2020
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
Kuga A, Otsubo T, Tsuji T, Hayashi S, Imagawa H, Fujikoshi S, Escobar R
Neuropsychiatric Disease and Treatment 2019, 15:809-817
Published Date: 5 April 2019
Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin
Enomoto H, Yasuda H, Nishiyori A, Fujikoshi S, Furukawa M, Ishida M, Takahashi M, Tsuji T, Yoshikawa A, Alev L
Journal of Pain Research 2018, 11:1857-1868
Published Date: 13 September 2018
Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine
Tokuoka H, Nishihara M, Fujikoshi S, Yoshikawa A, Kuga A
Neuropsychiatric Disease and Treatment 2017, 13:2457-2467
Published Date: 25 September 2017
An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
Kuga A, Tsuji T, Hayashi S, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T
Neuropsychiatric Disease and Treatment 2017, 13:2115-2124
Published Date: 4 August 2017
An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T
Neuropsychiatric Disease and Treatment 2017, 13:2105-2114
Published Date: 4 August 2017
Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
Alev L, Fujikoshi S, Yoshikawa A, Enomoto H, Ishida M, Tsuji T, Ogawa K, Konno S
Journal of Pain Research 2017, 10:1723-1731
Published Date: 24 July 2017
Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies
Enomoto H, Fujikoshi S, Funai J, Sasaki N, Ossipov MH, Tsuji T, Alev L, Ushida T
Journal of Pain Research 2017, 10:1357-1368
Published Date: 1 June 2017
Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
Ogawa K, Fujikoshi S, Montgomery W, Alev L
Neuropsychiatric Disease and Treatment 2015, 11:2101-2107
Published Date: 18 August 2015
Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study
Takahashi M, Nakahara N, Fujikoshi S, Iyo M
Pragmatic and Observational Research 2015, 6:39-46
Published Date: 14 July 2015
One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study
Ye W, Fujikoshi S, Nakahara N, Takahashi M, Ascher-Svanum H, Ohmori T
Pragmatic and Observational Research 2012, 3:41-49
Published Date: 14 June 2012